CPT 11042 Wound Debridement: Excisional Coding and Documentation
CPT 11042 for excisional wound debridement — clinical criteria, tissue depth requirements, documentation that prevents downcoding, and Medicare reimbursement rates.
Damon Ebanks
Medipyxis
What Is CPT 11042?
CPT 11042 reports excisional debridement of skin and subcutaneous tissue for the first 20 square centimeters of wound surface area. Excisional debridement means the clinician used a sharp instrument to cut through devitalized tissue until reaching a viable tissue plane -- the defining characteristic is that viable, bleeding tissue is exposed at the wound base or margins when debridement is complete.
This is the critical distinction from selective debridement (97597). Selective removes dead tissue from the surface. Excisional cuts past dead tissue until healthy tissue is reached. The clinical hallmark is active bleeding at the debridement margin. If the clinician did not debride to a viable plane, the procedure is selective regardless of what instrument was used.
How does the excisional debridement depth hierarchy work?
The 11042-11044 code series is organized by the deepest tissue layer the clinician excised to. The code is determined by the deepest structure reached, not the tissue removed along the way:
11042 -- Skin and subcutaneous tissue. The debridement reached viable subcutaneous fat with active bleeding. This is the most commonly billed excisional code in outpatient wound care.
11043 -- Muscle and/or fascia. The debridement extended past subcutaneous tissue to expose viable muscle or fascial planes. This code has significantly higher reimbursement and significantly higher audit scrutiny. The note must explicitly describe the muscle or fascial tissue reached.
11044 -- Bone. The debridement exposed viable bone. This is rare in outpatient settings and almost always triggers payer review. Documentation must describe bone reached and the clinical necessity for debridement to that depth.
Each code has a corresponding add-on for area >20 sq cm: 11045 pairs with 11042, 11046 pairs with 11043, and 11047 pairs with 11044. The add-on must match the tissue depth of the primary code.
What documentation prevents downcoding?
Downcoding -- the payer reducing 11042 to 97597 on review -- happens when the clinical note does not clearly establish that excisional debridement was performed. The documentation must answer the question: did you reach viable tissue?
Describe the tissue plane reached. "Debrided adherent necrotic tissue to the level of subcutaneous fat" or "excised eschar to viable subcutaneous tissue" -- the note must name the deepest tissue type the debridement reached. "Debridement performed" without specifying depth is not defensible for any excisional code.
Document active bleeding. "Active bleeding noted at wound base after debridement" or "pinpoint bleeding at wound margins confirming viable tissue reached." Bleeding is the objective evidence that excisional debridement occurred. Without it, the payer has no basis to distinguish excisional from selective.
Record the instrument and technique. Scalpel, curette, rongeur, scissors -- name it. While the instrument alone does not determine the code, it supports the clinical narrative. A scalpel excision is consistent with excisional debridement; it is less consistent with surface-only slough removal.
Pre- and post-debridement wound assessment. Wound dimensions and tissue composition before and after the procedure. The "before" description should show devitalized tissue. The "after" description should show viable tissue exposed by the debridement -- a visible change in the wound bed that confirms tissue was excised, not just wiped away.
Wound surface area debrided. Measured in square centimeters. Required for determining whether add-on codes (11045-11047) apply and for justifying the unit count.
What does Medicare reimburse for 11042?
The 2026 Medicare Physician Fee Schedule national average for 11042 is approximately $125-$150 in the non-facility (office) setting. The deeper codes reimburse progressively more: 11043 averages $245-$295, and 11044 averages $310-$370. Locality adjustments apply.
The revenue difference between 97597 ($80-$90) and 11042 ($125-$150) is approximately $40-$60 per visit. Over a panel of patients seen weekly, the annual difference from consistent undercoding is substantial. But upcoding carries compliance risk -- billing 11042 when the documentation supports only selective debridement is one of the most common wound care audit triggers.
For modifier rules and NCCI bundling considerations on excisional debridement codes, see our debridement billing guide. For the complete wound care CPT reference, see our 2026 CPT code guide.